Previous 10 | Next 10 |
Teligent (NASDAQ: TLGT ): Q2 Non-GAAP EPS of -$0.04 in-line; GAAP EPS of -$0.08 beats by $0.03 . More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2019. Second Quarter 2019 Highlights Net revenues of $18.3 million fo...
BUENA, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday August 5 th , 2019 to discuss the 2 nd quarter 2019 financial results and busin...
BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and MedTech Conference June 19, 2019. The Conference is taking place June 18 th - June 19 th , 20...
Teligent, Inc. (TLGT) Q1 2019 Results Conference Call May 06, 2019 04:30 PM ET Company Participants Jason Grenfell-Gardner - President and CEO Damian Finio - CFO Conference Call Participants Lucas Baranowski - Craig-Hallum Capital Lucas Lee - Raymond James Presentation ...
Teligent (NASDAQ: TLGT ): Q1 Non-GAAP EPS of -$0.09 misses by $0.02 ; GAAP EPS of -$0.16. More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
BUENA, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights Net revenues of $13.1 million for...
BUENA, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday May 6 th , 2019 to discuss the 1 st quarter 2019 financial results and bus...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Teligent, Inc. (“Teligent” or the “Company”) (NASDAQ: TLGT ) investors concerning the Company and its officers’ possible violations of federal securities laws. ...
BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development partner has filed the response to the Complete Response Letter (“CRL”) it receive...
News, Short Squeeze, Breakout and More Instantly...
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash collateral on a consensual basis Canadian entities to pursue sale process outside of Chap...
3 Penny Stocks to Watch With September Halfway Done With September already at the halfway point, there are plenty of penny stocks that investors are watching. And while it may seem easy at first to find valuable penny stocks to buy, it does take some time and a dedication to researc...
BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update. “Product demand in our core busin...